Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
Fader, Amanda Nickles
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. [electronic resource] - Gynecologic oncology Mar 2009 - 558-62 p. digital
Publication Type: Journal Article; Multicenter Study
1095-6859
10.1016/j.ygyno.2008.11.016 doi
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Brachytherapy
Carboplatin--administration & dosage
Carcinoma, Papillary--drug therapy
Combined Modality Therapy
Cystadenocarcinoma, Serous--drug therapy
Disease Progression
Female
Humans
Middle Aged
Neoplasm Recurrence, Local--pathology
Paclitaxel--administration & dosage
Retrospective Studies
Uterine Neoplasms--drug therapy
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. [electronic resource] - Gynecologic oncology Mar 2009 - 558-62 p. digital
Publication Type: Journal Article; Multicenter Study
1095-6859
10.1016/j.ygyno.2008.11.016 doi
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Brachytherapy
Carboplatin--administration & dosage
Carcinoma, Papillary--drug therapy
Combined Modality Therapy
Cystadenocarcinoma, Serous--drug therapy
Disease Progression
Female
Humans
Middle Aged
Neoplasm Recurrence, Local--pathology
Paclitaxel--administration & dosage
Retrospective Studies
Uterine Neoplasms--drug therapy